- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Data Supplement
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Email this article to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Jia, X.
- Articles by Lydall, D.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Jia, X.
- Articles by Lydall, D.
Mec1 and Rad53 Inhibit Formation of Single-Stranded DNA at Telomeres of Saccharomyces cerevisiae cdc13-1 Mutants
Xindan Jiaa, Ted Weinertb, and David Lydallaa School of Biological Sciences, University of Manchester, Manchester M13 9PT, United Kingdom
b Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 85721
Corresponding author: David Lydall, University of Newcastle, Henry Wellcome Laboratory for Biogerontology Research, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE, United Kingdom., d.a.lydall{at}ncl.ac.uk (E-mail)
Communicating editor: A. NICOLAS
| ABSTRACT |
|---|
Here we examine the roles of budding-yeast checkpoint proteins in regulating degradation of dsDNA to ssDNA at unprotected telomeres (in Cdc13 telomere-binding protein defective strains). We find that Rad17, Mec3, as well as Rad24, members of the putative checkpoint clamp loader (Rad24) and sliding clamp (Rad17, Mec3) complexes, are important for promoting degradation of dsDNA in and near telomere repeats. We find that Mec1, Rad53, as well as Rad9, have the opposite role: they inhibit degradation. Downstream checkpoint kinases Chk1 and Dun1 play no detectable role in either promoting degradation or inhibiting it. These data suggest, first, that the checkpoint sliding clamp regulates and/or recruits some nucleases for degradation, and, second, that Mec1 activates Rad9 to activate Rad53 to inhibit degradation. Further analysis shows that Rad9 inhibits ssDNA generation by both Mec1/Rad53-dependent and -independent pathways. Exo1 appears to be targeted by the Mec1/Rad53-dependent pathway. Finally, analysis of double mutants suggests a minor role for Mec1 in promoting Rad24-dependent degradation of dsDNA. Thus, checkpoint proteins orchestrate carefully ssDNA production at unprotected telomeres.
TO understand the biochemical mechanisms underlying the DNA-damage response, it is essential to understand how checkpoint proteins interact with damaged DNA and affect repair pathways. Although cell cycle arrest and DNA repair were initially thought to be independent cellular responses to damaged DNA (![]()
![]()
![]()
![]()
![]()
![]()
Understanding the myriad roles of checkpoint proteins in regulating cell cycle arrest, transcription, DNA repair, and apoptosis, including roles in DNA metabolism discussed in this report, benefits from understanding the composition and proposed roles of different checkpoint protein complexes. Checkpoint signal transduction cascades comprise DNA-damage sensors that directly interact with damaged DNA, signal transduction proteins that transmit the checkpoint signal, mediators that act among signalers, and targets that affect cell cycle progression (![]()
![]()
![]()
![]()
![]()
Other checkpoint complexes include a proliferating cell nuclear antigen (PCNA)-type heterotrimer consisting of Rad17, Mec3, and Ddc1 in budding yeast. This complex also binds damaged DNA (![]()
![]()
![]()
![]()
![]()
A fourth protein important in checkpoint signaling is Rad9, which has been classified as a checkpoint mediator or adaptor protein (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Checkpoint sensor proteins probably perform several functions once they bind to DNA damage, including regulation of DNA-damage metabolism. A role for checkpoint proteins in DNA-damage metabolism was first shown by examining budding-yeast mutant cells with a defect in the telomere-binding protein Cdc13 (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Studies of the generation of ssDNA in cells with a defect in the Cdc13 telomere-binding protein revealed that checkpoint proteins in fact regulate ssDNA production themselves (![]()
![]()
![]()
Since it is generally thought that ssDNA is an important and universal component for recruiting checkpoint complexes and for activating cell cycle arrest (![]()
![]()
![]()
![]()
![]()
![]()
![]()
| MATERIALS AND METHODS |
|---|
Yeast strains:
Unless otherwise indicated, the strains used in this study are in the W303 background and were RAD5, rather than rad5-535 (![]()
![]()
Serial dilution and growth on plates:
Colony-purified yeast strains were inoculated into 2 ml YEPD (ade) grown overnight with aeration at 23°. Fivefold dilution series were set up in 96-well plates, and small, 3- to 4-µl aliquots of the dilution series were transferred to duplicate YPD (ade) plates using metal prongs. Plates that had been inoculated with samples of the fivefold dilution series were incubated until colonies formed and then were photographed.
Liquid culture, medial nuclear division, viability assays, and ssDNA protection:
Cells were cultured and collected for monitoring nuclear divisions and viability assays as described before (![]()
![]()
strains at YER186C (![]()
![]()
|
|
Quantitative amplification of ssDNA:
Quantitative amplification of ssDNA (QAOS) has been described in detail by ![]()
![]()
| RESULTS |
|---|
Rad17 and Mec3 are required to generate ssDNA at telomeres in Cdc13-defective cells:
The RAD24 genetic epistasis group is composed of RAD24, RAD17, MEC3, and DDC1. Mutations in any or all of these genes result in a similar set of phenotypes (![]()
![]()
mutants at the restrictive temperature, but other members of the RAD24 group have not been tested (![]()
![]()
and mec3
mutations with cdc13-1 (bar1 and cdc15-2 mutations) and measured cell cycle arrest and ssDNA production at telomeres. BAR1 encodes a secreted protease and a bar1 mutation makes cells more sensitive to the peptide, mating pheromone, and
-factor. CDC15 is involved in mitotic exit and a cdc15-2 mutation ensures that checkpoint-defective cdc13-1 mutants do not undergo additional rounds of DNA replication at restrictive temperatures (![]()
Cell cycle arrest was determined from nuclear morphology of fixed cells (![]()
![]()
![]()
We measured cell cycle arrest and ssDNA production in cells as they progressed through one cell cycle with a defective telomere-binding protein, Cdc13. We found that rad17
and mec3
mutants fail to arrest at the G2/M checkpoint in the absence of Cdc13, as previously reported (Fig 2B and Fig D). The slight delay shown by the rad17
strain in this experiment was not observed in repeated experiments.
We then tested whether Rad17 and Mec3 regulate ssDNA production in cdc13-1 mutants. We found that rad17
and mec3
mutants, like rad24
mutants, fail to generate large amounts of ssDNA, measured 14.5 kb from the right telomere of chromosome V (YER186C, Fig 2I) (![]()
![]()
and mec3
mutants failed to generate ssDNA in either RAD9+ cells or rad9
mutant cells (Fig 2G and data not shown). Therefore, we conclude that Rad17 and Mec3, and thus the checkpoint sliding clamp complex, are required for robust ssDNA production that accumulates near telomeres of cdc13-1 mutants. These experiments are consistent with the idea that Rad24 regulates ssDNA accumulation in Cdc13-defective cells by recruiting the Rad17-checkpoint sliding clamp complex, which then may tether an exonuclease that directly degrades DNA near telomeres.
Rad53 inhibits ssDNA production at telomeres in Cdc13-defective cells:
Rad9 is required to activate the Rad53-checkpoint kinase, which is important for signaling and cell cycle arrest (![]()
mutants in response to cdc13-1-induced damage (Fig 3B and Fig C; ![]()
![]()
![]()
|
We found that Rad53, like Rad9, inhibits ssDNA production, although its inhibitory role is not as profound as that of Rad9. In cdc13 rad53 mutants, ssDNA accumulates at the locus 30 kb from the telomere within 200 min (Fig 3D), clearly more rapidly than cdc13-1 RAD+ cells, which accumulate very little ssDNA at this locus but less rapidly than cdc13-1 rad9
cells, which accumulate ssDNA by 120 min (Fig 3G). Checkpoint double-mutant cdc13-1 rad9
rad53 strains accumulated ssDNA 30 kb from the telomere at a similar rate to cdc13-1 rad9
mutants (Fig 3D); thus the rad9
mutation is epistatic to the rad53 mutation. ssDNA production in rad53 mutants appears to occur by the same mechanism as it does in rad9
mutants, because ssDNA production in both rad53
and rad9
mutants requires an intact RAD24 gene; that is, ssDNA production at the 15- and 30-kb loci is eliminated in rad53
rad24
double mutants (Fig 3D and Fig E).
In summary we conclude that Rad53, like Rad9, inhibits Rad24- and Rad17-dependent ssDNA production at the telomeres in Cdc13-defective cells. The slower rate of ssDNA production in cdc13-1 rad53
compared to cdc13-1 rad9
mutants suggests that Rad9 inhibits ssDNA production in part by activating the downstream kinase Rad53 and in part by a second mechanism independent of Rad53. We favor a model in which the second mechanism involves Rad9 directly inhibiting nuclease activity (see DISCUSSION and data in Fig 7). However, we cannot exclude the possibility that the slower rate of ssDNA production in cdc13-1 rad53
compared to cdc13-1 rad9
mutants may be due to an indirect effect of slow cell cycle progression kinetics; the slower cell cycle progression in rad53 mutants may somehow slow degradation itself. We think this indirect mechanism of cell cycle progression on degradation is unlikely because wild-type and chk1
mutants have similar rates of ssDNA accumulation, although they have very different rates of cell cycle progression (see below).
|
|
|
|
Roles of other checkpoint protein kinases: Chk1 and Dun1 have no effect on ssDNA production near telomeres:
One explanation for the more rapid ssDNA production in rad9
mutants than in rad53
mutants is that Rad9 inhibits ssDNA production through both Rad53 and Chk1, two protein kinases known to act in parallel downstream of Rad9 in cell cycle arrest (see Introduction). And, as previously observed, we find that chk1
mutants, like rad53
mutants, are only partially defective at the metaphase/anaphase checkpoint in response to cdc13-1-induced damage (Fig 4B and Fig C; ![]()
mutants is entirely dependent on RAD9 and RAD24 (Fig 4B and Fig C). Therefore, we tested whether Chk1 regulates ssDNA production near telomeres in Cdc13-defective cells. We found that Chk1 neither contributes to ssDNA production nor inhibits it; chk1
mutants and RAD+ CHK+ cells behave nearly identically in ssDNA production at both the 15-kb and 30-kb loci tested (compare Fig 4D and Fig E, with Fig 4F). Note particularly that the time of onset of ssDNA production at the 15-kb locus, 120 min, is nearly identical in chk1
and CHK1 strains. (It is important to note that we do not consider the twofold higher levels of ssDNA in chk1
rad9
compared to rad9
mutants to be significant because of interexperimental variability.) Further evidence that Chk1 plays little role in ssDNA production and that the Rad53-independent role of Rad9 is not via Chk1 is given by the finding that cdc13-1 chk1
rad53
strains accumulate ssDNA at similar rates to cdc13-1 rad53
strains (compare Fig 3D and Fig E, with Fig 4D and Fig E).
We also tested whether the Dun1 checkpoint protein kinase that appears to act downstream or interdependently with Rad53 in cell cycle arrest might also have a role in ssDNA production. We confirmed that dun1
mutants have a partial arrest defect similar to that of rad53
mutants (![]()
mutants generate ssDNA virtually identically to chk1
and to wild-type cells (Fig 4, DF).
On this basis we conclude that protein kinase Chk1, which acts downstream of Rad9, and Dun1, which most likely acts downstream of Rad53 in cell cycle arrest, have no role in regulation of ssDNA production in Cdc13-defective cells. This suggests that Rad9 inhibits ssDNA production via both Rad53 and a second pathway that is yet to be defined.
Mec1 inhibits ssDNA production at telomeres:
Mec1 is a central checkpoint protein in budding yeast required for virtually all known DNA-damage checkpoint pathways. Mec1 is required for phosphorylation and activation of Rad9 and Rad53, both of which inhibit ssDNA production in Cdc13-defective cells (![]()
![]()
![]()
![]()
To test for roles of Mec1, we analyzed cell cycle arrest and ssDNA as performed with other checkpoint mutants in this study. We confirm that a mec1
mutation like rad9
, rad17
, rad24
, and mec3
mutations causes a complete failure of the DNA-damage responsive metaphase/anaphase checkpoint (Fig 6B and Fig C). On analyzing ssDNA production in mec1
mutants, we found greater production of ssDNA in mec1
mutants than in wild type at the locus 30 kb from the telomere and found that the accumulation of ssDNA apparently occurs by the same mechanism because it requires an intact RAD24 gene (Fig 6D and Fig E). This indicates that Mec1, like Rad9 and Rad53, has a prominent role in inhibiting ssDNA production.
In an attempt to then determine if Mec1 acts entirely through Rad9 to inhibit ssDNA production, we made an interesting observation that suggests dual roles for Mec1. We found that cdc13-1 mec1
mutants and cdc13-1 mec1
rad9
mutants accumulate ssDNA at the 30-kb locus at the same time,
200 min after release from G1 (Fig 6D). Recall that rad9
mutants accumulate ssDNA
120 min after release from G1 (Fig 6G), a full 80 min earlier than mec1
or mec1
rad9
mutants do. This shows that the mec1 mutation, in contrast to the rad53
mutation, is dominant to the rad9
mutation in regulating ssDNA production 30 kb from the telomere. We suggest that this result may be explained if Mec1, but not Rad53, plays some minor role in activating ssDNA production (see DISCUSSION and Fig 9).
|
|
To summarize, Mec1 and Rad53 have similar roles in inhibiting ssDNA because both single mutants have increased ssDNA production compared to wild-type cells. However, we infer that Mec1 has an additional role in promoting ssDNA production because MEC1+rad9
mutants generate ssDNA more quickly than do mec1
rad9
mutants. Rad53 does not have an additional role in promoting ssDNA production because rad53
rad9
and RAD53+ rad9
mutants have identical rates of ssDNA production. Therefore it appears that Mec1 contributes both to the generation of ssDNA through regulation of the Rad17, Mec3, Ddc1 complex and to the inhibition of ssDNA production through regulation of Rad9 and Rad53.
Mec1 and Rad53, in contrast to Rad9, specifically inhibit Exo1-dependent ssDNA:
We asked if there is a relationship between the two Rad9 inhibitory mechanisms, one Rad53 dependent and one Rad53 independent, and Exo1 activity. This is because recently we showed that Rad9 inhibits both Exo1 (a 5'3' exonuclease) and an unidentified nuclease (or nucleases) termed "ExoX" (M. ZUBKO, S. GUILLARD and D. LYDALL, unpublished results). Both Exo1 and ExoX act at telomeres of cdc13 mutants (![]()
exo1
strains still possess nuclease activity and generate high levels of ssDNA at telomeres (M. ZUBKO, S. GUILLARD and D. LYDALL, unpublished results). As previously observed, we found that ssDNA levels are high in cdc13 rad9
exo1
strains, low in cdc13 exo1
strains (M. ZUBKO, S. GUILLARD and D. LYDALL, unpublished results), and low in cdc13 rad53
exo1
and cdc13 mec1
exo1
strains (Fig 7A and Fig B). One explanation for these data is that Rad9 inhibits an Exo1-independent nuclease activity (ExoX) by Mec1- and Rad53-independent mechanisms. That is, in mec1 and rad53 mutants, Rad9 is still present and able to inhibit ExoX. We further infer that normally Mec1, Rad9, and Rad53 work together to regulate Exo1 activity.
ssDNA accumulation and loss of viability:
We previously reported that a rad24 mutation rescues the poor viability of rad9
mutant cells with defects in Cdc13 (![]()
mutation suppressed cell death in cdc13 rad9
cells but ssDNA still accumulated (M. ZUBKO, S. GUILLARD and D. LYDALL, unpublished results). We suggest that the Exo1 protein is somehow involved in converting ssDNA into some lethal event. Given this role of Exo1, we asked if other checkpoint proteins might also be involved in converting ssDNA to lethal lesions. We measured cell viability in cdc13 checkpoint single mutants and double mutants (e.g., cdc13 mec1
and cdc13 mec1
rad9
) and found three classes of response. First, we found that mec3
and rad17
mutations, like the rad24
mutation reported previously, both suppressed the loss of viability and decreased the amount of ssDNA that accumulates in cdc13-1 rad9
mutants. We believe the high viability in cdc13 rad17
rad9
strains, for example, is because ssDNA does not accumulate (data not shown). Second, we found that dun1
and chk1
mutations do not affect cell viability of cdc13 rad9
mutants, which is not surprising since they do not affect accumulation of ssDNA. Third, we find that rad53
and mec1
mutations act like an exo1
mutation; rad53
and mec1
mutations increase cell viability of cdc13 rad9
mutants yet they do not dramatically decrease the amount of ssDNA that accumulates in cdc13-1 rad9
cells, as rad24
, mec3
, and rad17
mutations do (presumably because Exo1 is still active). One simple explanation for our data is that ssDNA is not lethal per se, but is converted to some lethal event by the action of Mec1, Rad53, and Exo1. Recombination does not seem to be the lethal event because deletion of Rad52, which is required for all types of recombination events in budding yeast, does not rescue the loss in viability of cdc13-1 rad9
cells (Fig 8G).
| DISCUSSION |
|---|
The DNA-damage response relies on coordinated interactions between DNA repair and cell cycle arrest responses. DNA repair, like replication, is a highly choreographed yet potentially disruptive series of biochemical events that lead to restoration of an undamaged DNA structure. Checkpoint-dependent cell cycle arrest ensures that repair is completed before critical cell cycle transitions occur. It is thought that DNA repair events regulate the cell cycle response and vice versa, but few details are known about how these two aspects of the DNA-damage response affect each other (![]()
![]()
In this article we have examined how a large set of DNA-damage checkpoint protein complexes and pathways interact to regulate the accumulation of ssDNA. Our experiments support a model in which specific checkpoint proteins have one of three roles: promoting ssDNA production at unprotected telomeres of cdc13-1 mutants, activating a cascade to inhibit ssDNA production, or having no effect on ssDNA production (Fig 9). One protein complex, Mec1-Ddc2, appears to be able to both promote and inhibit degradation.
Checkpoint protein complexes required to activate ssDNA production:
We have found that components of both the Rad24-Rfc2-5-checkpoint clamp loading complex and the Rad17-checkpont sliding clamp complex are required for production of ssDNA (Fig 2, GI). Others have shown that Rad24p, in combination with the four small Rfc subunits, loads the Rad17, Mec3, and Ddc1 hetero-trimeric PCNA-type ring onto damaged telomeres (![]()
![]()
![]()
![]()
mutants (M. ZUBKO, S. GUILLARD and D. LYDALL, unpublished results). Therefore, ExoX is not Exo1.
The Mec1 protein kinase appears also to contribute to the activity of ExoX because cdc13-1 rad9
mec1
mutants do not generate ssDNA as rapidly as cdc13-1 rad9
MEC1+ mutants (Fig 1G and Fig H, and Fig 5D and Fig E). Since Mec1 is required for phosphorylation of Ddc1 after DNA is damaged (![]()
Checkpoint protein complexes required to inhibit ssDNA production:
We have shown previously that Rad9 inhibits ssDNA production near telomeres. We now show that Mec1 and Rad53, as well as Rad9, are all involved in inhibiting ssDNA production at telomeres in Cdc13-defective cells. Others have shown that Mec1-dependent phosphorylation of Rad9 occurs after DNA is damaged (![]()
![]()
![]()
![]()
rad9
mutants (disabled in pathways a and b) but not in cdc13 exo1
rad53
or cdc13 exo1
mec1
mutants (disabled in pathway a, but proficient in pathway b). Therefore, inhibitory pathway b is still able to inhibit ExoX in mec1 or rad53 mutants. The existence of Rad9-dependent, but Mec1-independent, responses to DNA damage (Fig 9A, pathway b) is supported by the observation that rad9 mec1 double mutants are more sensitive than corresponding single mutants to DNA damage (![]()
There are several plausible mechanisms by which Rad9 and Rad53 may counteract nuclease activity at telomeres. Rad9 or Rad53 may directly bind to nucleases to inhibit their activity. Rad53 may phosphorylate nucleases or nuclease inhibitors. Rad9 or Rad53 may affect chromatin structure and thereby inhibit nuclease movement through chromatin. For example, Rad53 interacts with the chromatin-remodeling protein Asf1 (![]()
![]()
ssDNA and cell death:
We previously observed a good correlation between the rapid accumulation of ssDNA at telomeres and rapid loss of viability strains carrying combinations of cdc13-1, rad9
, and rad24
mutations (![]()
, rad53
, and exo1
mutations each suppress the rapid loss in viability of cdc13-1 rad9
mutants but ssDNA still accumulates (this work and M. ZUBKO, S. GUILLARD and D. LYDALL, unpublished results). One plausible explanation for this is that ssDNA is cytotoxic only if Mec1, Rad53, and Exo1 convert it into a lethal lesion, for example, to a lesion that is not easily repaired (Fig 9B). Consistent with this idea are numerous examples of DNA repair pathways converting nonlethal lesions to lethal lesions in cells. For example, homologous recombination pathways convert ultraviolet (UV)-induced DNA damage to lethal lesions in helicase-defective srs2 mutants or spontaneous lesions to lethal lesions in srs2 sgs1 double mutants (![]()
![]()
cells.
In summary we have shown that orchestrated interactions between checkpoint pathways and damaged telomeres regulate cell cycle arrest, ssDNA production, and cell viability of cdc13 mutants. Further understanding of these interactions will be critical for understanding the DNA-damage response. Future studies should define the mechanisms by which Rad9 and Rad53 inhibit Exo1 activity and how other nuclease(s) are regulated by the checkpoint sliding clamp. It seems likely that similar mechanisms will regulate the DNA-damage response at other types of DNA damage and in other eukaryotic cells.
| ACKNOWLEDGMENTS |
|---|
We thank all members of our labs for input and comments on the manuscript. We thank M. P. Longhese for providing strains. X.J. was partially supported by the award of an Overseas Research Scholarship. D.L. is a Wellcome Senior Research Fellow in Basic Biomedical Science.
Manuscript received July 31, 2003; Accepted for publication November 7, 2003.
| LITERATURE CITED |
|---|
ADAMS, A., D. E. GOTTSHCLING, C. A. KAISER and T. STEARNS, 1997 Methods in Yeast Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
ALCASABAS, A. A., A. J. OSBORN, J. BACHANT, F. HU, and P. J. WERLER et al., 2001 Mrc1 transduces signals of DNA replication stress to activate Rad53. Nat. Cell Biol. 3:958-965.[CrossRef][Medline]
BERMUDEZ, V. P., L. A. LINDSEY-BOLTZ, A. J. CESARE, Y. MANIWA, and J. D. GRIFFITH et al., 2003 Loading of the human 91-1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro. Proc. Natl. Acad. Sci. USA 100:1633-1638.
BLANKLEY, R. T. and D. LYDALL, 2004 A domain of Rad9p specifically required for activation of Chk1 in budding yeast. J. Cell Sci. 117:601-608.
BOOTH, C., E. GRIFFITH, G. BRADY, and D. LYDALL, 2001 Quantitative amplification of single-stranded DNA (QAOS) demonstrates that cdc131 mutants generate ssDNA in a telomere to centromere direction. Nucleic Acids Res. 29:4414-4422.
CARR, A. M., 2002 DNA structure dependent checkpoints as regulators of DNA repair. DNA Repair 1:983-994.[CrossRef][Medline]
CARR, A. M., 2003 Beginning at the end. Science 300:1512-1513.
D'AMOURS, D. and S. P. JACKSON, 2002 The MRE11 complex: at the crossroads of DNA repair and checkpoint signalling. Nat. Rev. Mol. Cell Biol. 3:317-327.[CrossRef][Medline]
EMILI, A., 1998 MEC1-dependent phosphorylation of Rad9p in response to DNA damage. Mol. Cell 2:183-189.[CrossRef][Medline]
EMILI, A., D. M. SCHIELTZ, J. R. YATES, III, and L. H. HARTWELL, 2001 Dynamic interaction of DNA damage checkpoint protein Rad53 with chromatin assembly factor Asf1. Mol. Cell 7:13-20.[CrossRef][Medline]
FAN, H. Y., K. K. CHENG, and H. L. KLEIN, 1996 Mutations in the RNA polymerase II transcription machinery suppress the hyperrecombination mutant hpr1 delta of Saccharomyces cerevisiae. Genetics 142:749-759.[Abstract]
GANGLOFF, S., C. SOUSTELLE, and F. FABRE, 2000 Homologous recombination is responsible for cell death in the absence of the Sgs1 and Srs2 helicases. Nat. Genet. 25:192-194.[CrossRef][Medline]
GARDNER, R., C. W. PUTNAM, and T. WEINERT, 1999 RAD53, DUN1 and PDS1 define two parallel G(2)/M checkpoint pathways in budding yeast. EMBO J. 18:3173-3185.[CrossRef][Medline]
GARVIK, B., M. CARSON, and L. HARTWELL, 1995 Single-stranded DNA arising at telomeres in cdc13 mutants may constitute a specific signal for the RAD9 checkpoint. Mol. Cell. Biol. 15:6128-6138.[Abstract]
GILBERT, C. S., C. M. GREEN, and N. F. LOWNDES, 2001 Budding yeast Rad9 is an ATP-dependent Rad53 activating machine. Mol. Cell 8:129-136.[CrossRef][Medline]
GRANDIN, N., C. DAMON, and M. CHARBONNEAU, 2001 Cdc13 prevents telomere uncapping and Rad50-dependent homologous recombination. EMBO J. 20:6127-6139.[CrossRef][Medline]
GREEN, C. M., H. ERDJUMENT-BROMAGE, P. TEMPST, and N. F. LOWNDES, 2000 A novel Rad24 checkpoint protein complex closely related to replication factor C. Curr. Biol. 10:39-42.[CrossRef][Medline]
HU, F., A. A. ALCASABAS, and S. J. ELLEDGE, 2001 Asf1 links Rad53 to control of chromatin assembly. Genes Dev. 15:1061-1066.
KONDO, T., T. WAKAYAMA, T. NAIKI, K. MATSUMOTO, and K. SUGIMOTO, 2001 Recruitment of Mec1 and Ddc1 checkpoint proteins to double-strand breaks through distinct mechanisms. Science 294:867-870.
KUMAGAI, A. and W. G. DUNPHY, 2000 Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. Mol. Cell 6:839-849.[CrossRef][Medline]
LOU, Z., C. C. CHINI, K. MINTER-DYKHOUSE, and J. CHEN, 2003a Mediator of DNA damage checkpoint protein 1 regulates BRCA1 localization and phosphorylation in DNA damage checkpoint control. J. Biol. Chem. 278:13599-13602.
LOU, Z., K. MINTER-DYKHOUSE, X. WU, and J. CHEN, 2003b MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature 421:957-961.[CrossRef][Medline]
LYDALL, D., 2003 Hiding at the ends of yeast chromosomes: telomeres, nucleases and checkpoint pathways. J. Cell Sci. 116:4057-4065.
LYDALL, D. and T. WEINERT, 1995 Yeast checkpoint genes in DNA damage processing: implications for repair and arrest. Science 270:1488-1491.
LYDALL, D. and T. WEINERT, 1997 Use of cdc131-induced DNA damage to study effects of checkpoint genes on DNA damage processing. Methods Enzymol. 283:410-424.[Medline]
MAJKA, J. and P. M. BURGERS, 2003 Yeast Rad17/Mec3/Ddc1: a sliding clamp for the DNA damage checkpoint. Proc. Natl. Acad. Sci. USA 100:2249-2254.
MARINGELE, L. and D. LYDALL, 2002 EXO1-dependent single-stranded DNA at telomeres activates subsets of DNA damage and spindle checkpoint pathways in budding yeast yku70
mutants. Genes Dev. 16:1919-1933.
MELO, J. and D. TOCZYSKI, 2002 A unified view of the DNA-damage checkpoint. Curr. Opin. Cell Biol. 14:237-245.[CrossRef][Medline]
MELO, J. A., J. COHEN, and D. P. TOCZYSKI, 2001 Two checkpoint complexes are independently recruited to sites of DNA damage in vivo. Genes Dev. 15:2809-2821.
MITTON-FRY, R. M., E. M. ANDERSON, T. R. HUGHES, V. LUNDBLAD, and D. S. WUTTKE, 2002 Conserved structure for single-stranded telomeric DNA recognition. Science 296:145-147.
NYBERG, K. A., R. J. MICHELSON, C. W. PUTNAM, and T. A. WEINERT, 2002 Toward maintaining the genome: DNA damage and replication checkpoints. Annu. Rev. Genet. 36:617-656.[CrossRef][Medline]
OSBORN, A. J., S. J. ELLEDGE, and L. ZOU, 2002 Checking on the fork: the DNA-replication stress-response pathway. Trends Cell Biol. 12:509-516.[CrossRef][Medline]
PACIOTTI, V., G. LUCCHINI, P. PLEVANI, and M. P. LONGHESE, 1998 Mec1p is essential for phosphorylation of the yeast DNA damage checkpoint protein Ddc1p, which physically interacts with Mec3p. EMBO J. 17:4199-4209.[CrossRef][Medline]
PAULOVICH, A. G., R. U. MARGULIES, B. M. GARVIK, and L. H. HARTWELL, 1997 RAD9, RAD17, and RAD24 are required for S phase regulation in Saccharomyces cerevisiae in response to DNA damage. Genetics 145:45-62.[Abstract]
PELLICIOLI, A., C. LUCCA, G. LIBERI, F. MARINI, and M. LOPES et al., 1999 Activation of Rad53 kinase in response to DNA damage and its effect in modulating phosphorylation of the lagging strand DNA polymerase. EMBO J. 18:6561-6572.[CrossRef][Medline]
ROUSE, J. and S. P. JACKSON, 2002a Interfaces between the detection, signaling, and repair of DNA damage. Science 297:547-551.
ROUSE, J. and S. P. JACKSON, 2002b Lcd1p recruits Mec1p to DNA lesions in vitro and in vivo. Mol. Cell 9:857-869.[CrossRef][Medline]
SANCHEZ, Y., J. BACHANT, H. WANG, F. HU, and D. LIU et al., 1999 Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms. Science 286:1166-1171.
SCHWARTZ, M. F., J. K. DUONG, Z. SUN, J. S. MORROW, and D. PRADHAN et al., 2002 Rad9 phosphorylation sites couple Rad53 to the Saccharomyces cerevisiae DNA damage checkpoint. Mol. Cell 9:1055-1065.[CrossRef][Medline]
SOGO, J. M., M. LOPES, and M. FOIANI, 2002 Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects. Science 297:599-602.
STEWART, G. S., B. WANG, C. R. BIGNELL, A. M. TAYLOR, and S. J. ELLEDGE, 2003 MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421:961-966.[CrossRef][Medline]
TANAKA, K. and P. RUSSELL, 2001 Mrc1 channels the DNA replication arrest signal to checkpoint kinase Cds1. Nat. Cell Biol. 3:966-972.[CrossRef][Medline]
USUI, T., H. OGAWA, and J. H. PETRINI, 2001 A DNA damage response pathway controlled by Tel1 and the Mre11 complex. Mol. Cell 7:1255-1266.[CrossRef][Medline]
VAZE, M. B., A. PELLICIOLI, S. E. LEE, G. IRA, and G. LIBERI et al., 2002 Recovery from checkpoint-mediated arrest after repair of a double-strand break requires Srs2 helicase. Mol. Cell 10:373-385.[CrossRef][Medline]
VIALARD, J. E., C. S. GILBERT, C. M. GREEN, and N. F. LOWNDES, 1998 The budding yeast Rad9 checkpoint protein is subjected to Mec1/Tel1-dependent hyperphosphorylation and interacts with Rad53 after DNA damage. EMBO J. 17:5679-5688.[CrossRef][Medline]
WANG, B., S. MATSUOKA, P. B. CARPENTER, and S. J. ELLEDGE, 2002 53BP1, a mediator of the DNA damage checkpoint. Science 298:1435-1438.
WEINERT, T. A. and L. H. HARTWELL, 1988 The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241:317-322.
WEINERT, T. A. and L. H. HARTWELL, 1993 Cell cycle arrest of cdc mutants and specificity of the RAD9 checkpoint. Genetics 134:63-80.[Abstract]
ZHOU, B. B. and S. J. ELLEDGE, 2000 The DNA damage response: putting checkpoints in perspective. Nature 408:433-439.[CrossRef][Medline]
ZOU, L. and S. J. ELLEDGE, 2003 Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300:1542-1548.
This article has been cited by other articles:
![]() |
S. G. Addinall, M. Downey, M. Yu, M. K. Zubko, J. Dewar, A. Leake, J. Hallinan, O. Shaw, K. James, D. J. Wilkinson, et al. A Genomewide Suppressor and Enhancer Analysis of cdc13-1 Reveals Varied Cellular Processes Influencing Telomere Capping in Saccharomyces cerevisiae Genetics, December 1, 2008; 180(4): 2251 - 2266. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Segurado and J. F.X. Diffley Separate roles for the DNA damage checkpoint protein kinases in stabilizing DNA replication forks Genes & Dev., July 1, 2008; 22(13): 1816 - 1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.J Proctor, D.A Lydall, R.J Boys, C.S Gillespie, D.P Shanley, D.J Wilkinson, and T.B.L Kirkwood Modelling the checkpoint response to telomere uncapping in budding yeast J R Soc Interface, February 22, 2007; 4(12): 73 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Grandin and M. Charbonneau Control of the yeast telomeric senescence survival pathways of recombination by the Mec1 and Mec3 DNA damage sensors and RPA Nucleic Acids Res., February 16, 2007; 35(3): 822 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Pandita, G. G. Sharma, A. Laszlo, K. M. Hopkins, S. Davey, M. Chakhparonian, A. Gupta, R. J. Wellinger, J. Zhang, S. N. Powell, et al. Mammalian rad9 plays a role in telomere stability, s- and g2-phase-specific cell survival, and homologous recombinational repair. Mol. Cell. Biol., March 1, 2006; 26(5): 1850 - 1864. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Corda, S. E. Lee, S. Guillot, A. Walther, J. Sollier, A. Arbel-Eden, J. E. Haber, and V. Geli Inactivation of Ku-Mediated End Joining Suppresses mec1{Delta} Lethality by Depleting the Ribonucleotide Reductase Inhibitor Sml1 through a Pathway Controlled by Tel1 Kinase and the Mre11 Complex Mol. Cell. Biol., December 1, 2005; 25(23): 10652 - 10664. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. El-Shemerly, P. Janscak, D. Hess, J. Jiricny, and S. Ferrari Degradation of Human Exonuclease 1b upon DNA Synthesis Inhibition Cancer Res., May 1, 2005; 65(9): 3604 - 3609. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Malkova, M. L. Naylor, M. Yamaguchi, G. Ira, and J. E. Haber RAD51-Dependent Break-Induced Replication Differs in Kinetics and Checkpoint Responses from RAD51-Mediated Gene Conversion Mol. Cell. Biol., February 1, 2005; 25(3): 933 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Chappell and V. Lundblad Structural Elements Required for Association of the Saccharomyces cerevisiae Telomerase RNA with the Est2 Reverse Transcriptase Mol. Cell. Biol., September 1, 2004; 24(17): 7720 - 7736. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Zubko, S. Guillard, and D. Lydall Exo1 and Rad24 Differentially Regulate Generation of ssDNA at Telomeres of Saccharomyces cerevisiae cdc13-1 Mutants Genetics, September 1, 2004; 168(1): 103 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wysocki and S. J. Kron Yeast cell death during DNA damage arrest is independent of caspase or reactive oxygen species J. Cell Biol., August 2, 2004; 166(3): 311 - 316. [Abstract] [Full Text] [PDF] |
||||
- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Data Supplement
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Email this article to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Jia, X.
- Articles by Lydall, D.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Jia, X.
- Articles by Lydall, D.















